The new normal at Syngene

COVID-19 is not going to go away in the immediate future and Syngene is adapting quickly to this ‘new normal’. We are not only ensuring continuity of our current business operations, but are also open to new business.

Simultaneously, we are committed to protecting our workforce, minimizing business disruptions and playing our part in improving human health. This includes contributing to the government’s initiatives to combat COVID-19.

As a result, Syngene’s three-pronged strategy to combat COVID-19 is focused on the following:

Protect our employees and contractors
Ensure business continuity
Leverage our R&D capabilities to combat COVID-19

Syngene's 'Putting Science to Work' Live Chat Series

COVID-19 is affecting us all in a way none of us could have imagined possible at the beginning of the year. Work from home, social distancing and being in quarantine seems to be the new normal. Every company and individual is struggling to adapt to this reality.

In such a scenario, enabling collaboration and unfettered exchange of ideas becomes all the more important. With that in mind, we launched a “Live-Chat” series hosted by our CCO Ashu Tandon. The chat involves a 45 minutes discussion on topics that are of importance to scientists and the scientific community at large, to help them move forward in these difficult times.

Watch past episodes of our Live-Chat series

Play